Ken Londoner: BioSig is a tech platform company

Connecticut company BioSig Tech, began generating revenue from product sales, last November, after winning Food & Drug Administration approval in 2018 to sell its PURE EP system.

The PURE EP system is a signal processing technology intended to help doctors with the treatment of cardiovascular diseases.

The past few years, BioSig has been building a legal wall around its core technologies. Last year alone, BioSig has felt for more than two-dozen patents.

Ken Londoner, BioSig’s Chairman and President said that signal processing technology could be engineered for other applications. Autonomously driven vehicles, which require the instantaneous and accurate interpretation of potential hazards in their path, whether close or distant, is posibly to be included.

The head of engineering of the medical device company, BioSig Tech is Barry Keenan. Diabetes system have been previously developed by him at the company Medtronic. His work also included the first artificial pancreas, a belt-mounted device. This device tests blood sugar levels every five minutes and administers insulin as needed. Time Magazine cited this device in 2013, as one of the top 25 inventions of the year.

Today, BioSig has just over 40 employees today. About 15 of them are in Westport and Los Angeles and 10 in Minnesota at the Mayo Clinic, near where the manufacturer of BioSig’s is located.

It has been anticipated by Ken Londoner that there will be needed a larger space before starting to hire new personnel. Ken Londoner has the intention to keep the company’s headquarters in Connecticut. He laments state government’s approach toward business regulations and taxes during BioSig’s tenure as a growth-stage company. He has said that they will double the company’s size this year. He points out that when people look at BioSig, which is now a public company, they see a medical technology company, a product company. Ken Londoner clarifies that he looks at BioSig as a tech platform company. He points out that the reason to line up all these patents is because of their know-how in taking noise out of signals.